Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by ...
Jim Cramer, the host of Mad Money, cautioned viewers on Wednesday about the risks of blindly following the crowd in the stock ...
Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...
Snack Foods Corp. (NASDAQ:JJSF), a leader in the snack food industry, announced the results of its annual meeting of shareholders held on February 12, 2025. The company, known for its diverse ...
This week's dividend activity included increased payouts from Gilead Sciences (GILD) and Meta Platforms (NASDAQ:META) as well as declarations from companies such as Nike (NYSE:NKE) and Unilever (UL).
Today on The Panel, Tim Beveridge is joined by Luke Dallow and Irene Gardiner to discuss the biggest stories from the week that was. Bill introduced ...
Johnson & Johnson MedTech announced that it intends to resume the rollout of its Varipulse platform in the U.S. after a temporary pause.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results